Xylitol

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Joseph Zabner

Overview

Xylitol is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.

Xylitol clinical trials

NCT00928135 (Phase 1)NCT01355796 (Phase 1)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about Xylitol for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.